The interaction between the renin-angiotensin system and nitric oxide (NO) is undeniable,
but its nature is not fully known. This study investigated the contribution of NO to the acute …

Abstract Three groups of New Zealand white rabbits were used to study the effects of
captopril on the renin-angiotensin system and sympathetic nervous system during sodium …

The impact of oral captopril, 2 mg [middle dot] kg-1, on the dose and on the hemodynamic
and hormonal effects of nitroprusside was studied in seven patients (Group II). A comparable …

The present investigation was performed to evaluate the effects of S-nitrosocaptopril, a novel
vasodilator possessing the capacities of both an angiotensin converting enzyme inhibitor …

The effect of an oral angiotensin I converting enzyme inhibitor, SQ 14225 (Captopril) on
blood pressure and plasma renin activity (PRA) was studied in deoxycorticosterone-salt …

The aim of the study was to assess whether angiotensin converting enzyme (ACE) inhibition
with captopril prevents the development of hypertension and myocardial hypertrophy and …

Chronic inhibition of nitric oxide (NO) synthesis is characterized by increased blood
pressure accompanied with both cardiac hypertrophy as well as renal damage. We …

Recently, in vivo and in vitro studies have implicated nitric oxide as a mediator of the
vascular effects of angiotensin-converting enzyme inhibitors (ACEIs). In the present study we …

An endothelium-derived relaxing factor has been identified as nitric oxide (NO). Peripheral
and central administration of nitric oxide synthase inhibitors result in an increase in renal …

To determine if clinically effective doses of the antihypertensive agent captopril affected the
neuronal release of norepinephrine or baroreflex sensitivity, changes in plasma …